Bachrodt Amy's Form 4 filing
Maze Therapeutics, Inc. (MAZE) · filed Jan 26, 2026
- Accession no.
- 0002050422-26-000005
- Filed
- Jan 26, 2026
- Trade date
- Jan 22, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $227.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bachrodt AmyCIK 0002050422 | Officer (SVP, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Common Stock | MOption exerciseAcquired | +2,497 | $10.42 | +$26,018.74 | 15,462 | Direct | |
| Jan 22, 2026 | Common Stock | MOption exerciseAcquired | +2,503 | $10.42 | +$26,081.26 | 17,965 | Direct | |
| Jan 22, 2026 | Common Stock | SSaleDisposed | −5,000 | $45.52 | −$227,600 | 12,965 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Common Stock | MOption exerciseDisposed | −2,497 | $0.00 | $0 | 486 | Direct | |
| Jan 22, 2026 | Common Stock | MOption exerciseDisposed | −2,503 | $0.00 | $0 | 7,869 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.